TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $754,766 | -1.9% | 41,769 | -31.7% | 0.00% | – |
| Q1 2023 | $769,008 | -7.5% | 61,178 | +7.8% | 0.00% | – |
| Q4 2022 | $831,721 | +19.5% | 56,734 | +39.5% | 0.00% | – |
| Q3 2022 | $696,000 | +11.9% | 40,663 | -4.6% | 0.00% | – |
| Q2 2022 | $622,000 | +32.1% | 42,617 | +52.3% | 0.00% | – |
| Q1 2022 | $471,000 | -12.5% | 27,982 | +17.1% | 0.00% | – |
| Q4 2021 | $538,000 | -12.7% | 23,904 | -16.5% | 0.00% | – |
| Q3 2021 | $616,000 | -30.2% | 28,614 | -6.0% | 0.00% | – |
| Q2 2021 | $882,000 | -6.5% | 30,428 | +4.0% | 0.00% | – |
| Q1 2021 | $943,000 | +17.7% | 29,259 | +51.1% | 0.00% | – |
| Q4 2020 | $801,000 | – | 19,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |